SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?

被引：1
|
作者：
Theodorakopoulou, Marieta P. [1 ]
Sarafidis, Pantelis [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol 1, Thessaloniki, Greece
来源：
CLINICAL KIDNEY JOURNAL | 2024年 / 17卷 / 01期
关键词：
CHRONIC KIDNEY-DISEASE;
D O I：
10.1093/ckj/sfad272
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Yousaf, Zohaib
    Ata, Fateen
    Khan, Adeel Ahmad
    Razok, Almurtada
    Akram, Jaweria
    Ali, Elrazi Awadelkarim Hamid
    Abdalhadi, Ahmed
    Danjuma, Mohammed I.
    Al Mohanadi, Dabia Hamad S. H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1431 - 1433
  • [22] SGLT2 inhibitors and diabetic retinopathy progression
    Nadelmann, Jennifer Beth
    Miller, Charles G.
    McGeehan, Brendan
    Yu, Yinxi
    VanderBeek, Brian L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [23] Diabetic ketosis/ketoacidosis with SGLT2 inhibitors
    Reactions Weekly, 2019, 1754 (1) : 5 - 5
  • [24] SGLT2 Inhibitors in Diabetic Kidney Disease
    Zoungas, Sophia
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (04): : 631 - 633
  • [25] SGLT2 inhibitors and the risk of diabetic ketoacidosis
    Redford, Christopher
    Doherty, Laura
    Smith, Jamie
    PRACTICAL DIABETES, 2015, 32 (07) : 263 - 264A
  • [26] Risk of diabetic ketoacidosis with SGLT2 inhibitors
    Reactions Weekly, 2015, 1566 (1) : 1 - 1
  • [27] SGLT2 inhibitors and diabetic retinopathy progression
    Jennifer B. Nadelmann
    Charles G. Miller
    Brendan McGeehan
    Yinxi Yu
    Brian L. VanderBeek
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 753 - 758
  • [28] SGLT2 inhibitors and diabetic retinopathy progression
    Nadelmann, Jennifer B.
    Miller, Charles G.
    Mcgeehan, Brendan
    Yu, Yinxi
    Vanderbeek, Brian L.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (03) : 753 - 758
  • [29] SGLT2 Inhibitors and Fracture Risk in Individuals with Advanced CKD
    Issa, Rochell
    Fardi, Yasameen
    Brateanu, Andrei
    Negrea, Lavinia Aura
    Dobre, Mirela A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [30] ADVANCING DKD AND CKD TREATMENT WITH SGLT2 INHIBITORS AND KERENDIA
    Staudt, Meghan
    Pearson-Bey, Charisse
    Robinson, Jennifer
    Hurtado, Tucker
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S105 - S105
12345